Image de couverture de livre

Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Daniela Gorski, Raul Edison Luna Lazo, Dalton de Assis de Souza, Helena Hiemisch Lobo Borba, Roberto Pontarolo, Fernanda Stumpf Tonin
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Predictors and Clinical Outcomes of Long‐Term Opioid Therapy in Older Adults: A Systematic Review
par: Iftekhar Ahmed, et autres
Publié: (2026)

Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy
par: Elmar R. Alizadeh, et autres
Publié: (2024)

Thromboembolic Risk of Thrombopoietin Receptor Agonists for Adult Primary Immune Thrombocytopenia: A Systematic Review and Meta‐Analysis Integrating Randomized Controlled Trials and Prospective Evidence
par: Meng‐Fei Dai, et autres
Publié: (2025)

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy
par: Jennifer N. Clements, et autres
Publié: (2026)

Cancer Therapy‐Induced Cardiotoxicity: A Narrative Review
par: Drew A. Wells, et autres
Publié: (2026)

Harnessing the Power of Artificial Intelligence to Enhance Drug Therapy Research
par: William L. Baker, et autres
Publié: (2026)

Constructing a Personalized Treatment Rule for Initial Therapy in Early Parkinson's Disease
par: Zachary P. Brehm, et autres
Publié: (2025)

Oritavancin for Treatment of Osteomyelitis: A Systematic Review and Meta‐Analysis of Observational Studies
par: Martin Krsak, et autres
Publié: (2025)

External Validation of the Fraser Equation for Estimation of Free Valproate Concentrations in Critically Ill Adults
par: Andrew J. Webb, et autres
Publié: (2025)

Bayesian Dosing Simulator ( BDS ): A Pharmacokinetic Modeling Tool for Optimized Antibiotic Therapy
par: Adrian Valadez, et autres
Publié: (2026)

Utilizing Machine Learning to Identify Predictors of Corticosteroid Discontinuation 1‐Year After Adult Heart Transplant
par: Caroline Chen, et autres
Publié: (2025)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
par: Amira R. Rashdan, et autres
Publié: (2026)

Hyperfiltration in Critically Ill Older Adults: Incidence, Risk Factors, Time Course, and Predictive Performance of Kidney Function Estimation
par: Ryusei Mikami, et autres
Publié: (2026)

Machine Learning Algorithms for Predicting Injurious Fall Risk Among Older Adults With Depression: A Prognostic Modeling Study
par: Grace Hsin‐Min Wang, et autres
Publié: (2025)

Drug–Drug Interactions and Combination Therapy Strategies of Amiodarone With Digoxin, Rivaroxaban, and Phenytoin Assessed by Physiologically Based Pharmacokinetic Modeling
par: Youjun Chen, et autres
Publié: (2025)

Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis
par: Wenqiang Zhou, et autres
Publié: (2026)

SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
par: Erin F. Barreto, et autres
Publié: (2026)

Beyond Monotherapy: The Superior Efficacy of Combined GLP ‐1 Receptor Agonist and SGLT2 Inhibitors on Renal Biomarkers: A Systematic Review and Meta‐Analysis
par: Aya M. AbdelMagid, et autres
Publié: (2026)

Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or Remitted Depression”
Publié: (2025)

Lithium Augmentation in Treatment‐Resistant Depression: A Qualitative Review of the Literature
par: Angela Acero‐González, et autres
Publié: (2025)

Effect of creatine monohydrate on motor function in children with facioscapulohumeral muscular dystrophy: A multicenter, randomized, double‐blind placebo‐controlled crossover trial
par: Ian R. Woodcock, et autres
Publié: (2025)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
par: Alexandre Duong, et autres
Publié: (2024)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
par: Maryam Aghakouchakzadeh, et autres
Publié: (2026)

Cancer Treatment Modalities and Female Fertility Preservation
par: Seonga Song, et autres
Publié: (2026)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
par: Mohammed Al Musawa, et autres
Publié: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
par: Atif Siddiqui
Publié: (2025)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
par: Jiwon Kim, et autres
Publié: (2025)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
par: Hua‐Ping Fan, et autres
Publié: (2024)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
par: Keith A. Rodvold
Publié: (2026)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
par: Nicolette Centanni, et autres
Publié: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
par: Yi‐Fan Chien, et autres
Publié: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
par: Amanda Massmann, et autres
Publié: (2025)

In Search of Big Beautiful Biomarkers
par: C. Lindsay DeVane
Publié: (2025)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
par: Carlos Augusto Espinoza Cobeñas
Publié: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
par: Lisa T. Hong, et autres
Publié: (2024)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
par: Nihal El Rouby, et autres
Publié: (2025)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
par: Trisha Matsuura, et autres
Publié: (2025)

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
par: Kathleen A. Stringer, et autres
Publié: (2025)

Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
par: Shibing Tao, et autres
Publié: (2024)

Oral β‐Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point‐Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones
par: Ashlan J. Kunz Coyne, et autres
Publié: (2026)